Publication Type : Journal Article
Publisher : Current Pharmaceutical Biotechnology
Source : Current Pharmaceutical Biotechnology, 2021, 22(7), pp. 906-919
Url : https://pubmed.ncbi.nlm.nih.gov/32767920/
Keywords : Quercetin; ‘Ayurveda’; ‘COVID 19’; ‘Phytochemical’; ‘Traditional medicine’.
Campus : Kochi
School : School of Pharmacy
Department : Pharmacognosy
Year : 2021
Abstract : SARS-CoV 2 is a novel virus strain of Coronavirus, reported in China in late December 2019. Its highly contagious nature in humans has prompted WHO to designate the ongoing pandemic as a Public Health Emergency of International Concern. At this moment, there is no specific treatment and the therapeutic strategies to deal with the infection are only supportive, and prevention aimed at reducing community transmission. A permanent solution for the pandemic, whichhas brought the world economy to the edge of collapse, is the need of the hour. This situation has brought intense research intraditional systems of medicine. Indian Traditional System, Ayurveda has a clear concept of the cause and treatment of pandemics. Through this review, information on the potential antiviral traditional medicines along with their immunomodulatory pathways is discussed. We have covered the seven most important Indian traditional plants with antiviral properties:Withaniasomnifera (L.) Dunal(family: Solanaceae),Tinosporacordifolia(Thunb.)Miers (family:Menispermaceae),Phyllanthusemblica L.(family:Euphorbiaceae),Asparagus racemosus L.(family:Liliaceae), Glycyrrhizaglabra L.(family:Fabaceae), Ocimum sanctum L.(family:Lamiaceae) and Azadirachta indicaA.Juss(family:Meliaceae)in this review. An attempt is also made to bring into limelight the importance of dietary polyphenol, Quercetin which is a potential drug candidate in the making against the SARS-CoV2 virus.
Cite this Research Publication : Adithya J., Bhagyalakshmi Nair, Aishwarya S., and Lekshmi R Nath, “The Plausible role of Indian Traditional Medicine in combating Corona Virus (SARS-CoV 2): a mini-review”, Current Pharmaceutical Biotechnology, 2021, 22(7), pp. 906-919